瑞马唑仑与丙泊酚用于老年胃切除术全麻的术后谵妄与恢复质量非劣效性研究
本研究为随机非劣效性试验,纳入≥65岁择期胃切除术患者461例,比较瑞马唑仑与丙泊酚维持全麻。分析432例(每组216例),术后72小时内谵妄发生率两组均为7.9%(17/216),未调整OR 1.00(95%CI 0.50-2.02,p=1.000);术后24小时恢复质量评分两组相似(中位数109 vs 109,p=0.627)。结论认为瑞马唑仑可作为丙泊酚的替代选择。
要点
- 瑞马唑仑组与丙泊酚组术后72h谵妄发生率均为7.9%,OR 1.00(95%CI 0.50-2.02)。
- 术后24h恢复质量评分两组中位数均为109,p=0.627,无显著差异。
- 老年胃切除术患者全麻维持可考虑瑞马唑仑替代丙泊酚。
核心结论
- 从术后谵妄发生率和恢复质量角度看,瑞马唑仑可作为丙泊酚的替代用于老年胃切除术患者全麻维持。
研究设计与样本
- 随机非劣效性研究,纳入≥65岁择期胃切除术患者461例,按1:1随机分配至瑞马唑仑组或丙泊酚靶控输注组,最终432例纳入分析(每组216例)。
主要发现
- 术后72小时内谵妄发生率瑞马唑仑组17/216(7.9%),丙泊酚组17/216(7.9%),未调整OR 1.00(95%CI 0.50-2.02,p=1.000)。
- 术后24小时恢复质量评分(QoR-15韩文版)中位数(IQR[范围])瑞马唑仑组109(102-115[54-140]),丙泊酚组109(104-115[70-137]),p=0.627;未调整OR -0.03(95%CI -0.19-0.13)。
- 两组术后恶心、干呕和呕吐发生率相似。
关键数值与推荐
- 谵妄评估采用混淆评估法(CAM),于术后72小时内进行。
- 恢复质量采用翻译的韩文版15项恢复质量问卷(QoR-15)于术后24小时评估。
临床怎么用
- 对于≥65岁胃切除术患者,瑞马唑仑维持全麻在谵妄发生率和恢复质量方面不劣于丙泊酚,可作为丙泊酚的替代选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Due to its haemodynamic stability and rapid recovery from anaesthesia, remimazolam is an attractive hypnotic drug for general anaesthesia in older patients. However, remimazolam must show non-inferiority in terms of the incidence of delirium and quality of postoperative recovery to be used as an alternative to propofol for maintenance of general anaesthesia. METHODS: Patients aged ≥ 65 y scheduled to undergo gastrectomy were randomly allocated to maintenance of general anaesthesia with a remimazolam infusion (remimazolam group) or propofol target-controlled infusion (propofol group) in a 1:1 ratio. The primary outcome measure was the incidence of delirium within 72 h of surgery (assessed using the confusion assessment method). Secondary outcomes included the quality of recovery at 24 h postoperatively (assessed using the translated Korean version of the 15-item Quality of Recovery questionnaire) and the incidence of postoperative nausea, retching and vomiting. RESULTS: Of 461 patients randomly allocated in the study, 432 were included in the analysis (216 in each group). The incidence of delirium was 17/216 (7.9%) in patients allocated to the remimazolam group and 17/216 (7.9%) in those allocated to the propofol group (unadjusted odds ratio 1.00, 95%CI 0.50-2.02, p = 1.000). Quality of recovery scores were also similar between groups at 24 h postoperatively (median (IQR [range]) 109 (102-115 [54-140]) vs. 109 (104-115 [70-137]) for the remimazolam and propofol groups, respectively (p = 0.627); unadjusted odds ratio -0.03, 95%CI -0.19-0.13). DISCUSSION: Remimazolam can be used as an alternative to propofol in older patients undergoing gastrectomy from the perspective of the incidence of postoperative delirium and quality of recovery.
引用
- Sim JH, Kim KM, Lee U, et al. Incidence of postoperative delirium and quality of recovery in older patients undergoing gastrectomy under general anaesthesia with remimazolam vs. propofol: a randomised non-inferiority study. Anaesthesia. 2025. PMID: 40653956. doi:10.1111/anae.16684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。